Loading
SH
Streamline Health Solutions Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Stilwill Benjamin Louis, was filed 24 Sept 2024.
Streamline Health Solutions Inc.: what insiders have been doing
Streamline Health Solutions Inc., classified in the Healthcare & Pharma sector, is a listed company. Its insiders report their share dealings to SEC (Form 4). No insider at Streamline Health Solutions Inc. has published a filing in the past twelve months. The most recent one dates from 14 August 2025.
Since 2016, the database holds 45 purchases and 5 sales by insiders of the company.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
253
Thresholds
n/a
Buy Volume
€4M
45 ops. · all time
Sell Volume
€154,603
5 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended January 2025 · cache
Income statement
RevenueUS$15.4M
Gross profitUS$12.6M82% margin
Net income-US$8.7M-56.8% margin
Last declaration on 14 August 2025
Declarations253 total
4,833 sharesCommon Stock, $0.01 par valueSEC:0001437749-25-026815:1
69,845 sharesCommon Stock, $0.01 par valueSEC:0001437749-25-026824:1
92,294 sharesCommon Stock, $0.01 par valueSEC:0001437749-25-026806:1
3 sharesCommon Stock, $0.01 par valueSEC:0001437749-25-026821:1
16,666 shares@ US$5.341.6% of flowCommon Stock, $0.01 par valueSEC:0000919574-25-004947:1
30,876 sharesCommon Stock, $0.01 par valueSEC:0001437749-25-026809:0
27,216 sharesCommon Stock, $0.01 par valueSEC:0001437749-25-026827:0
36,849 sharesCommon Stock, $0.01 par valueSEC:0001437749-25-026821:0
13,515 sharesCommon Stock, $0.01 par valueSEC:0001437749-25-026818:0
75,820 sharesCommon Stock, $0.01 par valueSEC:0001437749-25-026813:0
96,278 sharesCommon Stock, $0.01 par valueSEC:0001437749-25-026815:0
78,416 sharesCommon Stock, $0.01 par valueSEC:0001437749-25-026806:0
79,437 sharesCommon Stock, $0.01 par valueSEC:0001437749-25-026824:0
321,614 shares@ US$5.3456.7% of flowCommon Stock, $0.01 par valueSEC:0000919574-25-004947:0
7,008 shares@ US$5.292.3% of flowCommon Stock, $0.01 par valueSEC:0001437749-25-023800:0
6,919 shares@ US$5.302.3% of flowCommon Stock, $0.01 par valueSEC:0001437749-25-023228:0
794 shares@ US$2.260.4% of flowCommon Stock, $0.01 par valueSEC:0001437749-25-018333:0
1,168 shares@ US$2.260.2% of flowCommon Stock, $0.01 par valueSEC:0001437749-25-018334:0
1,156 shares@ US$2.934.9% of flowCommon Stock, $0.01 par valueSEC:0001437749-25-014140:0
1,156 shares@ US$2.930.8% of flowCommon Stock, $0.01 par valueSEC:0001437749-25-014144:0
1,264 shares@ US$2.934.0% of flowCommon Stock, $0.01 par valueSEC:0001437749-25-014143:0
766 shares@ US$3.670.7% of flowCommon Stock, $0.01 par valueSEC:0001437749-25-012385:1
1,264 shares@ US$2.720.9% of flowCommon Stock, $0.01 par valueSEC:0001437749-25-012385:2
1,542 shares@ US$2.720.2% of flowCommon Stock, $0.01 par valueSEC:0001437749-25-012383:1
1,310 shares@ US$2.720.9% of flowCommon Stock, $0.01 par valueSEC:0001437749-25-012382:1
25 of 253 declarations
About Streamline Health Solutions Inc.
Streamline Health Solutions, Inc. (ticker: STRM) is a U.S.-based healthcare software company listed on the NASDAQ in the United States. For investors, the company sits in a specialized corner of health tech: it does not deliver clinical care, but instead sells software and services that help hospitals and health systems improve financial performance. Its core value proposition is to reduce revenue leakage, strengthen billing accuracy and compliance, and improve the economics of the hospital revenue cycle. ([investor.streamlinehealth.net](https://investor.streamlinehealth.net/news-releases/news-release-details/streamline-healthr-reports-fiscal-first-quarter-2025-financial?utm_source=openai))
The company has a long operating history in healthcare IT. Streamline says it has been in business for more than 30 years, and its SEC records show a long-standing public-market presence in the United States. It is incorporated in Delaware and headquartered in Atlanta, Georgia, United States. Over time, Streamline has shifted from broader enterprise content management and analytics offerings toward a more focused platform centered on revenue integrity and hospital financial performance. ([investor.streamlinehealth.net](https://investor.streamlinehealth.net/?utm_source=openai))
Read moreShow less
Today, Streamline’s business is built around SaaS solutions, technology-enabled services, and analytics for healthcare providers. Its best-known offerings include RevID and eValuator, along with related tools and services for clinical documentation integrity, pre-bill review, charge reconciliation, and identification of missed revenue opportunities. The company’s messaging consistently emphasizes automated charge capture, improved billing accuracy, and reduced compliance exposure. This makes the model more recurring and software-driven than a legacy licensed-software business. ([investor.streamlinehealth.net](https://investor.streamlinehealth.net/news-releases/news-release-details/streamline-healthr-announces-signing-new-revidtm-contract-2300?utm_source=openai))
From a competitive standpoint, Streamline operates in a fragmented but demanding market. Its niche is the middle of the revenue cycle, where differentiation depends on measurable ROI, easy integration with existing EHR systems, and the ability to win and retain large institutional hospital customers. The company competes against larger healthcare software vendors and specialized revenue cycle management providers, so execution quality and product effectiveness matter more than broad product breadth. Recent contract wins with large health systems suggest a strategy focused on complex enterprise accounts rather than mass-market distribution. ([investor.streamlinehealth.net](https://investor.streamlinehealth.net/news-releases/news-release-details/streamline-healthr-announces-signing-new-revidtm-contract-2300?utm_source=openai))
Recent developments are important for equity investors. In May 2025, Streamline announced a definitive merger agreement under which MDaudit will acquire the company in an all-cash transaction valued at approximately $37.4 million including debt. In June 2025, the company reported fiscal first-quarter 2025 results, highlighting revenue growth and a higher mix of SaaS revenue, which underscores the ongoing transition toward a more recurring model. For investors tracking SEC Form 4 insider activity, these corporate events are material because they may influence trading behavior, liquidity, and the ultimate investment case. ([investor.streamlinehealth.net](https://investor.streamlinehealth.net/news-releases/news-release-details/mdaudit-and-streamline-health-announce-definitive-merger?utm_source=openai))
